TUMOR NECROSIS FACTOR ALPHA INHIBITORS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Ubago, R. [1 ]
Castillo, M. A. [1 ]
Marin, R. [2 ]
Flores, S. [3 ]
Rodriguez, R. [1 ]
机构：
[1] Agencia Evaluac Tecnol Sanitarias Andalucia, Seville, Andalucia, Spain
[2] Hosp Univ Virgen Rocio, Seville, Andalucia, Spain
[3] Andalusian Agcy Hlth & Technol Assessment, Seville, Andalucia, Spain
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.387
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [21] TREATMENT SATISFACTION WITH TUMOUR NECROSIS FACTOR-ALPHA INHIBITORS (ANTI-TNF) IN ANKYLOSING SPONDYLITIS
    Oksuzi, M. F.
    Balci, M. A.
    Tufan, A. N.
    Sahin, A. B.
    Gocken, A.
    Durmus, Y.
    Donmez, S.
    Dalkilic, E.
    Pamuk, O. N.
    Pehlivan, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1149 - 1149
  • [22] Serum interleukin-18 and tumor necrosis factor alpha in ankylosing spondylitis
    Zheng, DH
    Dal, L
    Wu, YM
    Han, ZJ
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 326 - +
  • [23] Gender Differences in Ankylosing Spondylitis: Men Derive Greater Benefit from Tumor Necrosis Factor Alpha Inhibitors
    Mandal, Jennifer
    Ward, Michael M.
    Weisman, Michael
    Simard, Jillian
    Brown, Matthew A.
    Lee, MinJae
    Rahbar, Mohammad H.
    Reveille, John D.
    Gensler, Lianne S.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [24] EVALUATION OF THE EFFICACY OF INHIBITORS OF TUMOR NECROSIS FACTOR ALPHA FOR PATIENTS WITH ANKYLOSING SPONDYLITIS IN REAL CLINICAL PRACTICE.
    Rozochkina, E.
    Koltsova, E.
    Murtazalieva, D.
    Zhilyaev, E.
    Koshkarova, E.
    Lukina, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1511 - 1512
  • [25] Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor α monoclonal antibody infliximab
    Brandt, J
    Haibel, H
    Cornely, D
    Golder, W
    Gonzalez, J
    Reddig, J
    Thriene, W
    Sieper, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2000, 43 (06): : 1346 - 1352
  • [26] Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis
    Betts K.A.
    Griffith J.
    Song Y.
    Mittal M.
    Joshi A.
    Wu E.Q.
    Ganguli A.
    Rheumatology and Therapy, 2016, 3 (2) : 323 - 336
  • [27] Anti Tumor Necrosis Factor Alpha (TNF alpha) Therapy in Ankylosing Spondylitis - Asian Perspective
    Lee, Tsz Yan
    Huang, Feng
    CURRENT RHEUMATOLOGY REVIEWS, 2009, 5 (03) : 158 - 164
  • [28] Targeting tumor necrosis factor receptors in ankylosing spondylitis
    Lata, Michal
    Hettinghouse, Aubryanna S.
    Liu, Chuan-ju
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2019, 1442 (01) : 5 - 16
  • [29] Effect of tumor necrosis factor inhibitors on spinal radiographic progression in patients with ankylosing spondylitis
    Jeong, Hyemin
    Eun, Yeong Hee
    Kim, In Young
    Park, Eun-Jung
    Kim, Hyungjin
    Lee, Jaejoon
    Jeon, Chan Hong
    Koh, Eun-Mi
    Cha, Hoon-Suk
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (05) : 1098 - 1105
  • [30] Effects of tumor necrosis factor-α inhibitors on new bone formation in ankylosing spondylitis
    Zhang, Jing-Ru
    Liu, Xiao-Juan
    Xu, Wei-Dong
    Dai, Sheng-Ming
    JOINT BONE SPINE, 2016, 83 (03) : 257 - 264
12345